In partnership with

See this week's breakthrough USPTO patent grants!

Stay up-to-date with AI

The Rundown is the most trusted AI newsletter in the world, with 1,000,000+ readers and exclusive interviews with AI leaders like Mark Zuckerberg, Demis Hassibis, Mustafa Suleyman, and more.

Their expert research team spends all day learning what’s new in AI and talking with industry experts, then distills the most important developments into one free email every morning.

Plus, complete the quiz after signing up and they’ll recommend the best AI tools, guides, and courses – tailored to your needs.

Sign up to start learning.

Table of Contents

• This Week's Patent News

• Weekly Statistics

• Main Article

• Trivia (question)

• Featured Inventor

• Today in Patent History

• Our Features

• Centurion Patentors

• Trivia (answer)

• Recommendations

This Week's Patent News:

1. UK House of Lords Pushes for Copyright Transparency in AI Bill – The UK House of Lords has insisted on greater transparency in AI-related copyright regulations, sparking debate among tech companies and rights holders.

2. Federal Circuit Rules Against Dolby Labs in Patent Dispute – The U.S. Court of Appeals for the Federal Circuit dismissed Dolby Laboratories' appeal, stating that the America Invents Act does not grant a freestanding right to identify real parties in interest.

3. USPTO Study Raises Questions About Large Patent Families – A recent USPTO study has led to concerns that the agency may be secretly engaging in additional examination and rejection of applications after claims were deemed allowable.

4. Japan IP High Court Awards Record Damages in Patent Case – In a landmark ruling, the Intellectual Property High Court of Japan awarded the highest-ever damages in a patent infringement lawsuit involving Toray Industries.

It was initially intended to treat angina, a type of chest pain caused by restricted blood flow to the heart. Early clinical trials, however, delivered lackluster results for angina relief but revealed an intriguing side effect: male participants were experiencing an inevitable "uplift."

It didn’t take long for Pfizer to pivot. Recognizing the potential to address erectile dysfunction, a condition shrouded in stigma but surprisingly common, they redirected their focus entirely. By 1998, Viagra was approved by the FDA, becoming the first oral treatment for ED. It was an instant blockbuster, raking over $400 million in its first year and fundamentally altering the cultural conversation about men’s health.

What makes Viagra’s story extraordinary isn’t just the science. It’s the marketing genius. Rather than target aging men with subtlety, Pfizer leaned into bold advertising, turning a once-taboo topic into prime-time discussion. It’s commercials became ubiquitous, and so did its euphemisms. Viagra isn’t just a pharmaceutical success story; it’s a tale of how science, serendipity, and a willingness to pivot can transform a men’s heart medication into a cultural and medical phenomenon. Plus, its proof that, sometimes, the best results come when you're not exactly aiming for them.

⚙️ Hungry for more invention stories like this?

Every week, IDiyas delivers real stories of inventors, forgotten breakthroughs, and the patents that shaped our world.
No fluff. Just the raw, remarkable power of human ingenuity.

👉 Subscribe to IDiyas now and join 40,000+ readers getting smarter about innovation—one patent at a time.

Fact-based news without bias awaits. Make 1440 your choice today.

Overwhelmed by biased news? Cut through the clutter and get straight facts with your daily 1440 digest. From politics to sports, join millions who start their day informed.

Sign up now!

Please scroll to the bottom of this newsletter to find out.

Jonathan Ive: The Design Mind Behind Apple’s Iconic Aesthetic Joins Forces with Sam Altman

Now, in a surprising and ambitious pivot, Ive is teaming up with Sam Altman, CEO of OpenAI, to build a new company aimed at reimagining the personal computing experience in the age of artificial intelligence. While details are still emerging, reports suggest the venture seeks to blend Ive’s human-centered design ethos with Altman’s cutting-edge AI ambitions, possibly creating a next-generation device that rivals the smartphone in influence.

It’s a powerful pairing: Ive brings a legacy of crafting emotionally resonant technology, while Altman brings the computational firepower of the world’s leading AI lab. Together, they may shape how AI becomes part of our daily lives, not just in software, but in beautiful, tangible form.

📬 The Clear Choice: How Americus Callahan’s Window Envelope Revolutionized Mail

Though seemingly simple, this innovation streamlined the mailing process for businesses across the country. It reduced labor, increased efficiency, and gave rise to the modern look of professional correspondence. Today, window envelopes are a staple in offices everywhere, used for sending bills, bank statements, paychecks, and the occasional mystery letter you’re not quite sure you want to open.

Americus Callahan may not be a household name, but every time you get one of those envelopes with your name already showing through the plastic pane, you’re experiencing a slice of his legacy. Proof that sometimes, true innovation is about knowing what not to cover up.

Congratulations to last week's Centurion Patentors!
We are excited to welcome the following inventors into these prestigious patent clubs:

For more info about their research & patents, click here

Answer is B. Provisional patent applications are available for utility and plant inventions.

Start learning AI in 2025

Keeping up with AI is hard – we get it!

That’s why over 1M professionals read Superhuman AI to stay ahead.

• Get daily AI news, tools, and tutorials

• Learn new AI skills you can use at work in 3 mins a day

• Become 10X more productive

Sign up and start mastering AI